Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment
- PMID: 32953767
- PMCID: PMC7475380
- DOI: 10.21037/atm.2020.03.81
Pulmonary regurgitation after repaired tetralogy of Fallot: surgical versus percutaneous treatment
Abstract
Pulmonary regurgitation is the most important sequellae after correction of Tetralogy of Fallot and has a considerable impact over the right ventricle. Surgery has demonstrated low early mortality after pulmonary valve replacement and good long-term outcomes, remaining nowadays the gold standard treatment of pulmonary regurgitation in rTOF patients. Nevertheless, transcatheter pulmonary valve implantation has emerged as a new, safe and efficient alternative to surgical valve replacement. In this review article, we try to evaluate and compare both techniques to find out which is the best therapeutic option in this patients.
Keywords: Tetralogy of Fallot (TOF); congenital heart disease; pulmonary regurgitation; pulmonary valve replacement; transcatheter pulmonary valve.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.03.81). The series “Structural Heart Disease: The Revolution” was commissioned by the editorial office without any funding or sponsorship. DHVP served as the unpaid Guest Editor of the series and serves as an unpaid editorial board member of Annals of Translational Medicine from Aug 2019 to Jul 2021. The authors have no other conflicts of interest to declare.
References
-
- Report of the New England Regional Infant Cardiac Program. Pediatrics 1980;65:375-461. - PubMed
-
- Fallot E. Contribution a lanatomie pathologique de la maladie bleue (cyanotic cardiaque). Marseille méd 1888;25:77,138,207,341,403.
Publication types
LinkOut - more resources
Full Text Sources